Theophylline

Product NDC
50111-482
11-digit product format
501110482
Labeler code
50111
Product ID
50111-482_7ead0af5-da03-4e84-8685-f469cfde4855
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Theophylline
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
Teva Pharmaceuticals USA, Inc.
Application
ANDA089808
Marketing category
ANDA
Marketing start
2010-09-13
Marketing end
0000-00-00
Substance
THEOPHYLLINE ANHYDROUS
Active strength
200 mg/1
Pharmacologic classes
Methylxanthine [EPC],Xanthines [CS]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d1d07c79-5983-427d-b6f5-df0550dcc598Product name420250325
7b1e3dc0-e6b1-4d5d-943b-99fdd948b5a2Product name120170302

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50111-482-01EA - Each50111-4828347a4b3-3008-4aaf-b5e1-430d0fdd981512012-07-24
50111-482-02EA - Each50111-48235721f76-50e2-461c-b950-f5125bd03bd112012-07-24
50111-482-03EA - Each50111-4824d19d5fd-4ee5-4696-9fcb-8a2eb298a70112012-07-24

DailyMed Socrata Ingredients#

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
237178theophylline 100 MG Extended Release Oral TabletPSN699a4e05-95cb-4b28-8927-d97a4afbf4631
346574theophylline 200 MG Extended Release Oral TabletPSN699a4e05-95cb-4b28-8927-d97a4afbf4631
317769theophylline 300 MG Extended Release Oral TabletPSN699a4e05-95cb-4b28-8927-d97a4afbf4631
237178theophylline 100 MG Extended Release Oral TabletSCD699a4e05-95cb-4b28-8927-d97a4afbf4631
346574theophylline 200 MG Extended Release Oral TabletSCD699a4e05-95cb-4b28-8927-d97a4afbf4631
317769theophylline 300 MG Extended Release Oral TabletSCD699a4e05-95cb-4b28-8927-d97a4afbf4631